Understanding how Francisella tularensis affects host cell responses

Modulation of Host Cell Responses by Francisella tularensis

NIH-funded research State University New York Stony Brook · NIH-10623247

This study looks at how the bacteria that cause tularemia, called Francisella tularensis, manages to hide from our immune system, focusing on a special protein named TolC that helps it survive and grow inside our cells, with the goal of finding new ways to understand and fight this infection.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionState University New York Stony Brook NIH-funded
Lab location1 site (Stony Brook, United States)
Project IDNIH-10623247 on NIH RePORTER

What this research studies

This research investigates the mechanisms by which the bacterium Francisella tularensis, responsible for the disease tularemia, evades the immune response of host cells. The study focuses on a specific protein called TolC, which plays a crucial role in the bacterium's ability to survive and replicate within host cells. By examining how TolC suppresses immune responses, the research aims to uncover new insights into the virulence of this pathogen and its interactions with the host's immune system.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who may be at risk of tularemia or have been exposed to Francisella tularensis.

Not a fit: Patients who are not at risk of tularemia or have no history of exposure to this bacterium may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating infections caused by Francisella tularensis.

How similar studies have performed: Other research has shown success in understanding bacterial pathogenesis through similar mechanisms, indicating that this approach has potential for yielding valuable insights.

Where this research is happening

Stony Brook, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Centers for Disease Control and Prevention (U.S.)Centers for Disease ControlCenters for Disease Control and PreventionUnited States Centers for Disease ControlUnited States Centers for Disease Control and Prevention
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.